Growth regulation of human breast carcinoma occurs through regulated growth factor secretion.
about
Autocrine growth factors and solid tumor malignancy.Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future?High-affinity insulin binding to an atypical insulin-like growth factor-I receptor in human breast cancer cells.Dual immunocytochemical analysis of oestrogen and epidermal growth factor receptors in human breast cancer.Expression of transforming growth factor beta mRNA isoforms in human breast cancerChanges in expression of transforming growth factor beta mRNA isoforms in patients undergoing tamoxifen therapyTumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularizationOverexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation.PDGF-A promoter and enhancer elements provide efficient and selective antineoplastic gene therapy in multiple cancer typesTransforming growth factor-beta--mullerian inhibiting substance family of growth regulators.Insulin-like growth factor-I (IGF-I) receptors in breast cancer.Comparative studies of the mitogenic effects of epidermal growth factor and transforming growth factor-alpha and the expression of various growth factors in neoplastic and non-neoplastic prostatic cell lines.Changes in epidermal growth factor receptor expression and response to ligand associated with acquired tamoxifen resistance or oestrogen independence in the ZR-75-1 human breast cancer cell line.Effect of estrogen and antiestrogens on cell proliferation and synthesis of secreted proteins in the human breast cancer cell line MCF-7 and a tamoxifen resistant variant subline, AL-1.Pharmacokinetic and pharmacodynamic properties of a long-acting formulation of the new somatostatin analogue, lanreotide, in normal healthy volunteers.A randomized, multicenter prospective trial assessing long-acting release octreotide pamoate plus tamoxifen as a first line therapy for advanced breast carcinoma.Transformation of mouse mammary epithelial cells with the Ha-ras but not with the neu oncogene results in a gene dosage-dependent increase in transforming growth factor-alpha production.
P2860
Q33559452-12289743-0393-4080-8309-FE684AA2A212Q35157568-7A81E8A3-1166-4B83-B509-5FCFBC3C8EF2Q35599265-63062E70-BDDF-4BCC-9974-9F78E1DBFD72Q35979084-6D5AA0AD-F660-46B1-8D6C-19ED515B725FQ35979175-98F381F5-2B46-40CC-B1B7-8CBDD20F9536Q36135815-66C2D6B5-F2D3-44E7-A35D-EB09D4BDA951Q36642174-EDEC1893-5724-4FDE-AD72-0CD60347F876Q36716270-86F17C05-DFAB-4D63-B7A5-0B4FEB8E75D1Q37314570-B07B0F5E-340B-405A-8D5A-B906B39E4522Q37365281-9F478513-FDC1-47F2-9581-B126B9E10755Q40999364-0300AE93-0DA0-4833-A84E-CB95F7127456Q41123032-A239C194-621C-422E-B0A4-2A601CF607BDQ41620522-8CC715C0-0B7D-4BA2-A44B-3E81057ADB3FQ41645493-A0E72CB0-73CB-4640-8F94-6CF479CEB41EQ43201636-388CD408-5A2F-4ECC-8245-2C856672D235Q43921035-BC9344FA-B287-4F0B-A5AB-C7959D6ADC3BQ53514352-97010CE0-0CF9-4679-98AD-6E25FE885FF2
P2860
Growth regulation of human breast carcinoma occurs through regulated growth factor secretion.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Growth regulation of human bre ...... lated growth factor secretion.
@en
Growth regulation of human bre ...... lated growth factor secretion.
@nl
type
label
Growth regulation of human bre ...... lated growth factor secretion.
@en
Growth regulation of human bre ...... lated growth factor secretion.
@nl
prefLabel
Growth regulation of human bre ...... lated growth factor secretion.
@en
Growth regulation of human bre ...... lated growth factor secretion.
@nl
P2093
P356
P1476
Growth regulation of human bre ...... lated growth factor secretion.
@en
P2093
Bronzert D
Dickson RB
Gelmann EP
Lippman ME
P356
10.1002/JCB.240350102
P577
1987-09-01T00:00:00Z